A2;3;4 |
astrocytoma grade 2;3;4 |
ADC |
apparent diffusion coefficient |
BBB |
blood–brain barrier |
BTV |
biological tumor volume |
CNS |
central nervous system |
CT |
computer tomography |
DWI |
Diffusion-weighted imaging |
E3 |
Ependymoma grade 3 |
EANO |
European Association of Neuro-oncology |
ETMR |
Embryonal tumor with multilayer rosettes |
FDG |
fluoro-deoxy-glucose |
FDOPA |
6-[18F]-L-fluoro-L-3, 4-dihydroxyphenylalanine |
FET |
O-(2-[18F]fluoroethyl)-L-tyrosine |
FLAIR |
fluid-attenuated inversion recovery |
GBM |
glioblastoma |
MET |
L-[11C]methyl-methionine |
MRI |
magnetic resonance imaging |
MRS |
magnetic resonance spectroscopy |
NCCN |
National Comprehensive Cancer Network |
O2;3 |
Oligodendroglioma grade 2;3 |
OSEM |
ordered subset expectation maximization |
PBL |
Bayesian penalized likelihood |
PET |
positron emission tomography |
PWI |
perfusion-weighted imaging |
rCBV |
relative cerebral blood volume |
TBR |
tumor brain ratio |
TOF |
time of flight |